These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 19414316)

  • 41. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.
    Belldegrun AS; Klatte T; Shuch B; LaRochelle JC; Miller DC; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Dekernion JB; Pantuck AJ
    Cancer; 2008 Nov; 113(9):2457-63. PubMed ID: 18823034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.
    Kim HJ; Cho HJ; Kim KS; Lee HS; Kim HJ; Jung E; Yoon JH
    J Craniomaxillofac Surg; 2008 Jan; 36(1):47-52. PubMed ID: 18312791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The effects of combined hepatectomy and immuno-chemotherapy on postoperative recurrence rate of primary liver cancer].
    Zhou W; Wu M; Chen H
    Zhonghua Wai Ke Za Zhi; 1995 Jan; 33(1):35-7. PubMed ID: 7774443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Locoregional adoptive immunotherapy using LAK cells and IL-2 against liver metastases from digestive tract cancer].
    Ueda Y; Sonoyama T; Itoi H; Fujiwara H; Fuji N; Itoh T; Fujiki H; Yamashita T; Yoshimura T; Harada S; Okugawa K; Yamagishi H
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1962-5. PubMed ID: 11086454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cancer of the kidney in adults. Treatment of the metastatic stage].
    Prog Urol; 1997 Nov; 7(5):879-95. PubMed ID: 9458484
    [No Abstract]   [Full Text] [Related]  

  • 46. Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.
    Pignata S; Ferrandina G; Scarfone G; Scollo P; Odicino F; Cormio G; Katsaros D; Frigerio L; Mereu L; Ghezzi F; Manzione L; Lauria R; Breda E; Alletti DG; Ballardini M; Vernaglia A; Sorio R; Tumolo S; Musso P; Magni G; Pisano C; Morabito A
    Crit Rev Oncol Hematol; 2009 Sep; 71(3):233-41. PubMed ID: 19179095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preoperative interleukin-2 immunotherapy in pancreatic cancer: preliminary results.
    Angelini C; Bovo G; Muselli P; Mussi C; Crippa S; Caprotti R; Uggeri F
    Hepatogastroenterology; 2006; 53(67):141-4. PubMed ID: 16506394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Postsurgical adjuvant immunotherapy against primary non-small cell lung cancer].
    Kimura H; Iwai N; Suzuki M; Takahashi Y
    Nihon Geka Gakkai Zasshi; 1998 May; 99(5):279-84. PubMed ID: 9656236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiation therapy, bypass operation and celiac plexus block in patients with unresectable locally advanced pancreatic cancer.
    Yamaguchi K; Kobayashi K; Ogura Y; Nakamura K; Nakano K; Mizumoto K; Tanaka M
    Hepatogastroenterology; 2005; 52(65):1605-12. PubMed ID: 16201126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience.
    Semino C; Martini L; Queirolo P; Cangemi G; Costa R; Alloisio A; Ferlazzo G; Sertoli MR; Reali UM; Ratto GB; Melioli G
    Anticancer Res; 1999; 19(6C):5645-9. PubMed ID: 10697634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer.
    Bjerregaard JK; Mortensen MB; Jensen HA; Fristrup C; Svolgaard B; Schønnemann KR; Hansen TP; Nielsen M; Johansen J; Pfeiffer P
    Radiother Oncol; 2009 Aug; 92(2):226-30. PubMed ID: 19435643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer.
    Rozková D; Tiserová H; Fucíková J; Last'ovicka J; Podrazil M; Ulcová H; Budínský V; Prausová J; Linke Z; Minárik I; Sedivá A; Spísek R; Bartůnková J
    Clin Immunol; 2009 Apr; 131(1):1-10. PubMed ID: 19201656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
    Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Adoptive immunotherapy with LAK cell and IL-2 against primary lung cancer].
    Kimura H; Yamaguchi Y
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1459-62. PubMed ID: 2586439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term outcomes of extended radical resection combined with intraoperative radiation therapy for pancreatic cancer.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T; Tanaka H; Chikamoto A; Horino K; Beppu T; Hirota M; Baba H
    J Hepatobiliary Pancreat Surg; 2008; 15(6):603-7. PubMed ID: 18987930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical analysis of 2340 cases of pancreatic cancer].
    Zhang QH; Ni QX;
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):214-8. PubMed ID: 15059537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Factors influencing the prognosis of carcinoma of the pancreas--an analysis of 155 cases].
    Okazaki H; Tajiri H; Yoshimori M; Nakamura K; Kinoshita T; Ozaki H
    Gan No Rinsho; 1989 May; 35(6):701-4. PubMed ID: 2724549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Significance of antitumor effects and immunological response on endogenously induced LAK therapy for primary or metastatic liver tumor].
    Miya K; Saji S; Furuta T; Azuma S; Umemoto T; Takao H; Katou M; Kanno A; Kaneda N; Yamawaki Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1453-6. PubMed ID: 1530292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.
    De Vleeschouwer S; Fieuws S; Rutkowski S; Van Calenbergh F; Van Loon J; Goffin J; Sciot R; Wilms G; Demaerel P; Warmuth-Metz M; Soerensen N; Wolff JE; Wagner S; Kaempgen E; Van Gool SW
    Clin Cancer Res; 2008 May; 14(10):3098-104. PubMed ID: 18483377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Bases on timing of combined modality of chemotherapy and immunotherapy].
    Ogura T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1414-20. PubMed ID: 1697153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.